GSK’s new R&D chief Hal Barron has made no secret of the fact that he has a keen interest in refocusing the R&D group at the pharma giant. And that’s starting to play out with some layoffs in its big R&D center at GSK’s Stevenage campus as well as its second big hub near Philadelphia. … Continue reading GlaxoSmithKline R&D reorganization triggers layoffs at Stevenage — and Upper Providence